ArticleGastrointestinal cancer research : GCR2012

A Multi-institutional Phase 2 Study of Imatinib Mesylate and Gemcitabine for First-Line Treatment of Advanced Pancreatic Cancer.

Rebecca A Moss et al.PubMed ↗Full text ↗

No numbers read from the abstract.